OBJECTIVES: To determine the prevalence of selfreported napping and its association with subjective nighttime sleep duration and quality, as measured according to sleep-onset latency and sleep efficiency. DESIGN: Cross-sectional study. SETTING: Lifestyle Interventions and Independence for Elders Pilot Study. PARTICIPANTS: Community-dwelling older adults (N 5 414) aged 70 to 89. MEASUREMENTS: Self-report questionnaire on napping and sleep derived from the Pittsburgh Sleep Quality Index (PSQI) scale. RESULTS: Fifty-four percent of participants reported napping, with mean nap duration of 55.0 AE 41.2 minutes. Nappers were more likely to be male (37.3% vs 23.8%, P 5.003) and African American (20.4% vs 14.4%, P 5.06) and to have diabetes mellitus (28% vs 14.3%, P 5.007) than non-nappers. Nappers and non-nappers had similar nighttime sleep duration and quality, but nappers spent approximately 10% of their 24-hour sleep occupied in napping. In a multivariate model, the odds of napping were higher for subjects with diabetes mellitus (odds ratio (OR) 5 1.9, 95% confidence interval (CI) 5 1.2-3.0) and men (OR 5 1.9, 95% CI 5 1.2-3.0). In nappers, diabetes mellitus (b 5 12.3 minutes, P 5.005), male sex (b 5 9.0 minutes, P 5.04), higher body mass index (b 5 0.8 minutes, P 5.02), and lower Mini-Mental State Examination score (b 5 2.2 minutes, P 5.03) were independently associated with longer nap duration.
A significant proportion of older adults report napping, with prevalence estimates ranging from 23% to 61%. 1, 2 Napping has generally been discussed in terms of its negative effect on sleep hygiene, particularly through longer sleep-onset latency, 3, 4 more nighttime awakenings, 5, 6 and less nighttime sleep. 7, 8 Given the older adult's greater risk of disrupted sleep quality and greater occurrence of fragmented sleep, any practice that may worsen nighttime sleep should be avoided. However, there is a gap in knowledge as to what specific effect napping has on nocturnal sleep and whether it is a marker of poor health.
Poor nighttime sleep and daytime sleepiness, which may be associated with napping, 9, 10 have detrimental effects on mood, attention, memory, and quality of life, along with public health concerns of increased fall risk, usage of sedating medications, and mortality in older adults. [11] [12] [13] [14] [15] The time that a nap occurs during the day, specifically an evening nap, may lead to disrupted sleep in older adults, especially less nocturnal sleep, which may occur because their circadian rhythms are altered. 8, 16 Large epidemiological studies of older adults have found napping to be an independent risk factor for mortality, especially cardiovascular mortality. More-recent data show that heart rate and blood pressure significantly increase after awakening from nocturnal and daytime sleep. [17] [18] [19] [20] [21] [22] Still others report that napping improves mood and cognitive performance and has little or no effect on nighttime sleep. 1, [23] [24] [25] [26] A few even report that napping may decrease coronary heart disease risk, depending on nap duration and health status. 27, 28 Despite the growing literature on napping, few studies have specifically addressed the prevalence of napping in sedentary community-dwelling adults who are not selected according specific sleep complaints. 8, 29 Furthermore, few studies have described the correlation between napping and comorbidity.
The objective was to characterize the prevalence of selfreported napping in a group of community-dwelling older adults with impaired physical performance and determine its association with nighttime sleep duration, sleep-onset latency, and sleep efficiency. It was also desired to determine whether other demographic factors, performance variables, and comorbid conditions are predictive of napping using standardized, interview-administered questionnaires in these community-dwelling older adults. It was hypothesized that self-reported napping was related to fewer hours of reported nighttime sleep, longer sleep-onset latency, and poorer sleep efficiency, along with a greater prevalence of comorbid psychological and physical illnesses in nappers.
METHODS

Data were collected on participants enrolled in the Lifestyle
Interventions and Independence for Elders Pilot Study (LIFE-P).
30,31 LIFE-P is a multicenter, single-blind, randomized, controlled clinical trial in which communitydwelling sedentary adults aged 70 to 89 who are at risk for disability were assigned to physical activity or a successful aging intervention lasting between 12 and 18 months depending on the month of randomization. The physical activity intervention consisted of a structured exercise program focused on walking, supplemented with behavioral counseling. The successful aging intervention consisted of educational meetings not expected to affect the main study outcomes. Participants were recruited primarily through direct mailings, but media (radio and newspaper advertisements, press releases, articles) and other community outreach efforts were also used. The goal of the LIFE-P was to obtain key design benchmarks in preparation for a larger study of the efficacy of physical activity for preventing disability in this population. The local institutional review boards of all four participating field centers (The Cooper Institute, Dallas, TX; Stanford University, Stanford, CA; University of Pittsburgh, Pittsburgh, PA; and Wake Forest University, Winston-Salem, NC) approved the study, and all enrolled participants gave written informed consent. The protocol is consistent with the principles of the Declaration of Helsinki and is registered at www.Clinical Trials.gov (NCT00116194).
The design and methods of the trial are described in detail elsewhere. 30, 31 Briefly, eligibility criteria included being able to walk 400 m within 15 minutes without sitting and without the use of any assistive device, having a Short Physical Performance Battery (SPPB) score (a standardized, well-documented measure of lower extremity physical performance that includes walking, balance, and strength tasks, scaled 0-12, higher scores indicating better performance 32 ) of 9 or less, having completed a 1-week behavioral practice trial before randomization, having given informed consent, living in the study area, and not planning to move for at least 9 months. Participants were ineligible if they had severe heart failure, uncontrolled angina pectoris, severe pulmonary disease, chest pain or severe shortness of breath during the 400-m walk test, severe arthritis, cancer requiring treatment in the previous 3 years, Parkinson's disease, other severe illness that might interfere with physical activity, illness with life expectancy of less than 12 months, or a Mini-Mental State Examination (MMSE) score less than 21. 32 Temporary exclusion criteria were acute myocardial infarction, deep venous thrombosis, pulmonary embolism, major arrhythmias, stroke within 6 months, recent major surgery, uncontrolled hypertension, uncontrolled diabetes mellitus, or ongoing lower extremity physical therapy.
Baseline cross-sectional data on nap duration and prevalence, nighttime sleep duration, sleep-onset latency, and sleep efficiency were collected in a standardized interview at baseline. Of the 424 participants, 414 had complete data on napping and sleep and are included in the analysis.
Napping and sleep were assessed using a standardized interview. Participants were asked, ''During the past month, how many hours did you nap or sleep during a typical day?'' Those reporting more than 0 minutes of napping were classified as nappers. The Pittsburgh Sleep Quality Index (PSQI) items 1 through 4 33 were used to assess the following sleep measures: total time in bed, nighttime sleep duration, sleeponset latency, and sleep efficiency.
Demographic variables assessed at baseline included age, sex, self-designated race, marital status, level of education, and self-report of smoking. Chronic health conditions considered as potential confounders (hypertension, diabetes mellitus, cancer, myocardial infarction, congestive heart failure, stroke, and pacemaker placement) were assessed according to self-report. Weight was assessed using a calibrated scale and height using a stadiometer. Body mass index (BMI; kg/m 2 ) was calculated. Cognition, mood, fatigue, and pain were also considered as potential confounders. Cognitive function was assessed using the Folstein MMSE, 32 depression symptoms using the Center for Epidemiologic Studies Depression (CES-D) Scale, 34 energy level using a six-item fatigue and energy questionnaire from the Modified Exercise-Induced Feeling Inventory, 30 and pain symptoms using a modified 12-item pain scale and a pain frequency scale.
30
Analysis Wilcoxon-Mann-Whitney t-tests and chi-square analyses were used to examine differences between means and categorical variables of nappers and non-nappers. Logistic regression was used to examine the odds of taking a daytime nap. Stepwise linear regression was conducted to assess predictors of nap duration (minutes) as a continuous outcome. All models were adjusted for variables associated with napping in univariate analysis or previous literature report. 11, 15 Variables that did not reach a significance of .10 or less were excluded from the final models.
RESULTS
Descriptive characteristics of the 414 participants are shown in Table 1 and are stratified according to napping status. Fifty-four percent of participants reported napping.
Average nap duration for nappers was 55.0 AE 41.2 minutes. Men reported napping more than women, and napping was more prevalent in African-American participants than in Caucasians and other racial and ethnic minorities but did not reach statistical significance. There was no difference in average age with respect to napping status.
Diabetes mellitus was more prevalent in participants who reported napping (Table 1) . Nappers had lower energy and fatigue scores than non-nappers, indicating that they had less energy. There was a marginal but nonsignificant difference in terms of higher BMI and higher CES-D score (indicating more depression symptoms) in nappers than in non-nappers. There was no difference in the prevalence of cardiovascular diseases between nappers and non-nappers (Table 1) .
Contrary to the hypothesis, there was no difference between any nighttime sleep parameters in terms of average reported nighttime sleep duration, sleep-onset latency, or w History of hypertension, myocardial infarction, congestive heart failure, stroke, or pacemaker placement.
SD 5 standard deviation.
sleep efficiency between nappers and non-nappers (Table 2) .
Although there was no difference in reported nighttime sleep duration between nappers and non-nappers, when accounting for total 24-hour sleep, nappers had longer total sleep duration than non-nappers, with approximately 10% of their total sleep occupied in napping (Table 2 ).
In the logistic regression model (Table 3) , the unadjusted odds ratio for nappers was higher in men and participants with diabetes mellitus. In the fully adjusted model, men and participants with diabetes mellitus had significantly higher odds of napping that adjustment for other factors did not attenuate (Table 3) .
Among nappers, male sex, diabetes mellitus, and higher BMI were all associated with longer nap duration in the unadjusted linear regression model, which continued to hold the same associations in the fully adjusted model (Table 4 ). In the fully adjusted model, lower MMSE scores also became associated with longer nap duration. Male sex was associated with 9-minute longer nap duration, whereas diabetes mellitus was associated with 12-minute longer nap duration. In the logistic and linear models, none of the nighttime sleep parameters were associated with napping status or duration.
DISCUSSION
Self-reported napping was common in this group of sedentary, community-dwelling older adults with impaired physical performance. The finding that 54% of older adults napped at least once a week is within the range that others have reported. 8, 26, 35, 36 Not all sleep studies routinely ask about nap behaviors. This study adds further evidence that the prevalence of napping in older adults is high and must be accounted for in sleep studies involving older adults.
This study failed to show a clear association between age and napping, unlike others that have shown that the prevalence of napping increases with age. 1, 26, 29, 37 The fact that the population had a narrower range of ages, focusing on the ''oldest'' old (70-89), whereas others have compared napping behavior between ''younger'' old (50-59) and ''oldest'' old (70-79), could explain this difference. Men napped significantly more than women, which others have noted. 1, 26, [38] [39] [40] Although few studies have specifically examined napping and race, the results of the current study suggest that African Americans nap more than other racial groups, a finding reported in two other studies. 41, 42 Reported poor sleep was not more prevalent in nappers than in non-nappers. There was no difference between nappers and non-nappers in terms of reported nighttime sleep duration, sleep-onset latency, or sleep efficiency. This finding is consistent with findings from other studies, 7, 29 one of which used objective measures to show that daytime sleep was not related to nocturnal sleep in postmenopausal women. 29 Although self-reported napping did not have a negative effect on reported nighttime sleep, as had been hypothesized, there is a speculation that napping may be a compensation for daytime sleepiness incurred from fragmented nighttime sleep. Sleep apnea 43 and sleep fragmentation due to nocturia 10, 44, 45 are two prevalent conditions that may not be reported as detracting from nocturnal sleep duration and quality but may contribute to daytime sleepiness and thus increase the propensity to nap. A recent population-based study suggested that napping could be regarded as a marker of sleep apnea, which could account for the incidence of cardiovascular disease observed in nappers. Data in that study showed that nappers had a higher frequency of sleep apnea than controls at three different cutoff points. 46 In addition, a study of female subjects with insomnia showed that habitual nap behavior was not related to subjective or objective measures of nocturnal sleep but was rather indicative of daytime sleepiness. 47 The finding that nappers spent 10% of 24-hour sleep occupied in napping, despite having no significant difference in nocturnal sleep parameters from non-nappers, may indicate this.
In this cohort, napping was more prevalent in participants with diabetes mellitus. The diagnosis of diabetes mellitus and higher BMI were also associated with longer nap duration. This finding provides a new piece of evidence that diabetes mellitus has an effect on daytime sleep. Others have described poorer nighttime sleep in people with diabetes mellitus, particularly with respect to altered sleep duration 48 and sleep-disordered breathing, 49, 50 along with higher rates of insomnia, hypnotic medication use, and daytime sleepiness, than in controls. 47 Studies correlating diabetes mellitus with greater daytime sleepiness have shown that daytime sleepiness was greatest in subjects with frequent nocturnal micturition episodes, somewhat explained by sleep apnea syndrome. 1 Further study with objective actigraphic or polysomnographic measurements of nighttime sleep and napping behavior is required to address such hypotheses.
A limitation of this study is the lack of a full sleephabits inventory or polysomnography. Given the nature of this ancillary study, within the larger framework of its parent study, participant burden limited it to a subset of questions from the PSQI that were previously shown to be prevalent in older adults recruited for exercise trials and responsive to a physical activity intervention. 51 Therefore, the potential importance of primary sleep disorders as potential correlates of napping cannot be addressed, although the finding of an association between napping and obesity and diabetes mellitus implicates sleep apnea and thus nocturnal arousals as a possible cause. Finally, a possible confounding variable not defined in the study was medication usage, especially hypnotics. Some reports do not show a correlation between hypnotics and daytime sleepiness, 1 whereas others have shown correlations between these medications and disturbed sleep 11, 52 and napping status. 26 Self-reported sleep disorders correlate poorly with polysomnography. Objective measures of nighttime sleep as well as of napping should be used in future research. Recent studies using objective assessment show underreporting of napping behavior when compared with actigraphic and polysomnographic measurements. 8, 29 It remains unclear whether napping should be an endorsed or discouraged practice, 2 with reports that a short nap may be beneficial to cognitive status, 1, [23] [24] [25] and other reports that napping increases mortality rate. 9, 11, 12 The current study provides further evidence that napping is a common practice of older adults and does not appear to worsen nighttime sleep. It provides evidence that napping behavior should always be assessed in sleep studies of older adults. It is also important for clinicians to ask about napping behavior and determine its relationship to daytime sleepiness and nighttime sleep before making clinical recommendations.
In summary, this is one of the first studies to show that people with diabetes mellitus are more likely to nap and subsequently sleep longer when day and nighttime sleep are considered together. It may be that napping is an indicator of silent comorbid disease complications. In this study population, nappers had a higher prevalence of diabetes mellitus, whereas cardiovascular disease has been extensively cited in the literature to be associated with napping and daytime sleepiness, particularly in survivors of myocardial infarction. [17] [18] [19] [20] [21] Although it remains unclear whether illness increases sleep need, older individuals who are sicker may report more sleep per day because of an increase in their subjective need for sleep. Because illness often reduces nighttime sleep quality, daytime napping may be an important mechanism for addressing their desire for more sleep.
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